Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;47(3):472-480.
doi: 10.1111/ijlh.14442. Epub 2025 Feb 25.

Genetic Diversity in KMT2A -r and KMT2A -Wt Groups: Assessing the Prognostic Value of Markers in BCP-ALL Among Infants

Karina Ilyasova  1 , Elena Zerkalenkova  1 , Olga Soldatkina  1 , Anna Kazakova  1 , Natalya Myakova  1 , Julia Roumiantseva  1 , Veronica Fomynih  1 , Alexander Popov  1 , Grigory Tsaur  2   3   4 , Yulia Olshanskaya  1 , Michael Maschan  1
Affiliations

Genetic Diversity in KMT2A -r and KMT2A -Wt Groups: Assessing the Prognostic Value of Markers in BCP-ALL Among Infants

Karina Ilyasova et al. Int J Lab Hematol. 2025 Jun.

Abstract

Background/objectives: Infant BCP-ALL is classified into KMT2A-r and KMT2A-wt groups, both showing heterogeneity. KMT2A rearrangements indicate poor prognosis, but outcomes vary by fusion partner. The KMT2A-wt group includes cases in the B-other ALL subgroup, with unclear prognostic significance. We aim to improve understanding of molecular subtypes in KMT2A-r and KMT2A-wt, focusing on NUTM1 and PAX5 rearrangements.

Methods: We analyzed 175 infants (aged 0-365 days) diagnosed with BCP-ALL from 2010 to 2023 at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Genomic aberrations were identified by karyotyping, FISH and RNA-seq. RNA-seq was performed using the Illumina, and gene fusions were validated by Sanger sequencing.

Results: There was no difference in survival based on KMT2A partner genes. The KMT2A::AFF1 group showed similar outcomes to other partners, with 2-year EFS of 36% (95% CI, 21%-59%) versus 37% (95% CI, 23%-60%) (log-rank test, p = 0.9). In the KMT2A-wt group (n = 33, 17.7% of cases), NUTM1-r (n = 9) and PAX5-r (n = 10) accounted for 27% and 30.3%, respectively. The NUTM1-r and PAX5-r groups showed excellent survival rates, with 2-year EFS of 80% (95% CI, 52%-100%) and 100% (95% CI, 100%-100%), respectively, but the small cohort size limit the statistical power of the analysis (log-rank test, p = 0.9).

Conclusions: Survival in the KMT2A-r group did not differ by fusion partner. NUTM1 rearrangements showed a favorable prognosis, and PAX5-rearranged patients had better outcomes than previously reported. In the NUTM1-r group, the most common fusion, BRD9:NUTM1, showed variability in breakpoints (Exons 3, 8, and 14 of BRD9).

Keywords: KMT2A rearranged and wild‐type; NUTM1; PAX5; genetic markers in infant leukemia; real‐life data.

PubMed Disclaimer

References

    1. A. Attarbaschi , A. Möricke , C. J. Harrison , et al., “Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study,” Journal of Clinical Oncology 41 (2023): 1404–1422.
    1. R. Pieters , P. De Lorenzo , P. Ancliffe , et al., “Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant‐06 Protocol: Results From an International Phase III Randomized Study,” Journal of Clinical Oncology 37 (2019): 2246–2256.
    1. C. Meyer , P. Larghero , B. Almeida Lopes , et al., “The KMT2A Recombinome of Acute Leukemias in 2023,” Leukemia 37 (2023): 988–1005.
    1. J. Wen , M. Zhou , Y. Shen , et al., “Poor Treatment Responses Were Related to Poor Outcomes in Pediatric B Cell Acute Lymphoblastic Leukemia With KMT2A Rearrangements,” BMC Cancer 22 (2022): 859, https://doi.org/10.1186/s12885‐022‐09804‐w.
    1. R. Marschalek , “Systematic Classification of Mixed‐Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways,” Annals of Laboratory Medicine 36 (2016): 85–100.

Substances

LinkOut - more resources